Uncover key drivers, emerging technologies, and competitive movements shaping the gastroretentive drug delivery systems outsourcing market from 2026–2035 with trusted insights from The Business Research Company
What market expansion outlook does the Gastroretentive Drug Delivery Systems Outsourcing Market show for the 2026–2030 period?
The gastroretentive drug delivery systems outsourcing market has experienced significant growth in recent years. It is projected to expand from $1.49 billion in 2025 to $1.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to various factors, including the limitations of conventional oral drug delivery methods, the increasing availability of contract research organization (CRO) services, the demand for improved drug absorption, the expansion of pharmaceutical pipelines, and advancements in formulation technology.
The gastroretentive drug delivery systems outsourcing market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $2.1 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is fueled by several factors, including the proliferation of complex drug molecules, a rising need for patient-focused delivery systems, the broadening of outsourcing approaches, advancements in gastroretentive technologies, and pharmaceutical companies’ pursuit of cost efficiencies. Key trends expected within this period encompass the increasing reliance on external partners for advanced drug delivery development, a heightened requirement for extended GI retention formulations, the growing popularity of floating drug delivery systems, an increase in CRO collaborations for formulation development, and a strong emphasis on improving drug bioavailability.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
What Drivers Are Shaping The Development Of The Gastroretentive Drug Delivery Systems Outsourcing Market?
The increasing occurrence of gastrointestinal ailments is anticipated to fuel the expansion of the gastroretentive drug delivery systems outsourcing market in the future. These ailments encompass a broad spectrum of conditions impacting the digestive system, specifically the stomach, liver, gallbladder, intestines, and pancreas. Several factors contribute to the rise in gastrointestinal disorders, including aging populations, antibiotic usage, infectious agents, dietary shifts, stress, lifestyle choices, and obesity. By outsourcing gastroretentive drug delivery systems, pharmaceutical firms gain access to the necessary resources and specialized knowledge to manage the increasing burden of gastrointestinal disorders, thereby enhancing patient health and overall quality of life. As an illustration, in August 2023, the National Institute of Diabetes and Digestive and Kidney Diseases, a US-based government-funded research institute and public health agency, stated that 60 to 70 million people were affected by various digestive diseases. Consequently, the growing prevalence of gastrointestinal disorders is a key impetus for the gastroretentive drug delivery systems outsourcing market. The expanding occurrence of age-related conditions is projected to stimulate the growth of the gastroretentive drug delivery systems in the future. Age-related disorders denote a wide array of health issues and functional limitations that primarily impact elderly individuals, such as cardiovascular diseases, neurodegenerative disorders, musculoskeletal conditions, and sensory impairments. The rise in these conditions can be attributed to an aging global population, extended life expectancy, various lifestyle factors, and the accumulation of chronic diseases. For example, in April 2025, the Centers for Disease Control and Prevention, a US-based government public health agency, indicated that in 2023, about 194 million American adults, comprising 6 in 10 young adults, 8 in 10 midlife adults, and 9 in 10 older adults, reported having one or more conditions. The prevalence of chronic conditions saw an increase of 7.0 percentage points among young adults. Consequently, the increasing prevalence of age-related disorders is a significant factor propelling the gastroretentive drug delivery systems outsourcing market.
Which Segments Are Contributing To The Growth Of The Gastroretentive Drug Delivery Systems Outsourcing Market?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) By Floating Systems: Single Unit Systems, Multiple Unit Systems
2) By Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) By Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
What Trends Are Reshaping The Dynamics Of The Gastroretentive Drug Delivery Systems Outsourcing Market?
Key companies within the gastroretentive drug delivery systems outsourcing market are concentrating on developing innovative products, such as ready-to-fill (RTF) colon functional capsules, to enhance drug delivery efficiency and improve patient convenience. The ready-to-fill (RTF) colon functional capsules refer to pre-manufactured, empty capsules intended to be filled with specific formulations or active ingredients designed for the colon. For instance, in September 2024, Evonik, a Germany-based advanced drug delivery provider, introduced EUDRACAP colon functional capsules, which are engineered for the targeted delivery of oral drugs to the ileo-colonic region. These groundbreaking capsules are the first ready-to-fill option accessible in the market, aimed at delivering sensitive active ingredients like live biotherapeutic products (LBPs). Currently offered in technical grade, a GMP-grade product is additionally under development. EUDRACAP colon optimizes the oral drug development process by simplifying formulation and accelerating time to market, making it a substantial advancement in gastroretentive drug delivery systems.
Who Are The Top-Performing Companies In The Gastroretentive Drug Delivery Systems Outsourcing Market In Recent Years?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, Evonik Industries AG, SGS SA, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc, Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Access The Complete Report For Deeper Market Insights:
How Does The Gastroretentive Drug Delivery Systems Outsourcing Market Perform Across Major Global Regions?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastroretentive Drug Delivery Systems Outsourcing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2026, By The Business Research Company
Advanced Drug Delivery Systems Market Report 2026
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Electronic Drug Delivery Systems Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model